Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping human disease-associated enzymes into Reactome allows characterization of disease groups and their interactions. | Sci Rep | 2022 | 36289281 | PubTator, text mining | PubMed |
| The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α. | Nat Commun | 2022 | 36289205 | PubTator, text mining | PubMed |
| Immunoproteasomes control activation of innate immune signaling and microglial function. | Front Immunol | 2022 | 36275769 | PubTator, text mining | PubMed |
| Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets. | Front Cell Infect Microbiol | 2022 | 36275035 | PubTator, text mining | PubMed |
| Identification of Melanoma Subsets Based on DNA Methylation Sites and Construction of a Prognosis Evaluation Model. | J Oncol | 2022 | 36268281 | PubTator, text mining | PubMed |
| A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. | PLoS One | 2022 | 36260611 | PubTator, text mining | PubMed |
| Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: A retrospective cohort study. | Elife | 2022 | 36250618 | PubTator, text mining | PubMed |
| The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases. | Front Immunol | 2022 | 36248893 | PubTator, text mining | PubMed |
| Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. | Cells | 2022 | 36230929 | PubTator, text mining | PubMed |
| PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer. | Cancer Res | 2022 | 36222718 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential hub genes and therapeutic drugs in an acquired lymphedema model. | Gland Surg | 2022 | 36221279 | PubTator, text mining | PubMed |
| Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax. | Cell Death Dis | 2022 | 36209148 | PubTator, text mining | PubMed |
| A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis. | Front Med (Lausanne) | 2022 | 36203777 | PubTator, text mining | PubMed |
| Genetic variation in genes of inborn errors of immunity in children with unexplained encephalitis. | Genes Immun | 2022 | 36198812 | PubTator, text mining | PubMed |
| [Induced pluripotent stem cell-derived rejuvenated cytotoxic T lymphocyte therapy for Epstein-Barr virus-associated lymphomas: application to clinical practice]. | Rinsho Ketsueki | 2022 | 36198557 | PubTator, text mining | PubMed |
| Amino acids at position 5 in the peptide/MHC binding region of a public virus-specific TCR are completely inter-changeable without loss of function. | Eur J Immunol | 2022 | 36189878 | PubTator, text mining | PubMed |
| The Emotional Anatomy of the Wuhan Lockdown: Sentiment Analysis Using Weibo Data. | JMIR Form Res | 2022 | 36166650 | PubTator, text mining | PubMed |
| Mechanisms of development and progression of pancreatic neoplasms. | Pathol Int | 2022 | 36161420 | PubTator, text mining | PubMed |
| Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma. | Front Immunol | 2022 | 36159865 | PubTator, text mining | PubMed |
| Evaluation of Epstein-Barr virus expression in oral squamous cell carcinomas. | Dent Res J (Isfahan) | 2022 | 36159061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=32